Citations (7)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Sabyasachi Ghosh, Ian Smith, James Davidson, Tao Fan, Ninfa Candela, Cynthia Tsang, Troy Koch & Jason Fehr. (2023) Payer-Addressable Burden of Crohn’s Disease in Members Treated with Biologics in the United States: Actuarial Analysis Findings from RAINBOW. North American Actuarial Journal 27:4, pages 619-629.
Read now
Read now
Articles from other publishers (6)
Irene Lizano-Díez, Sonia Amaral-Rohter, Lucía Pérez-Carbonell & Susana Aceituno. (2021) Impact of Home Care Services on Patient and Economic Outcomes: A Targeted Review. Home Health Care Management & Practice 34:2, pages 148-162.
Crossref
Crossref
José Diego Marques Santos, Juan Nicolás Peña-Sánchez & Sharyle A. Fowler. (2020) Patients’ perspectives on medication for inflammatory bowel disease: a mixed-method systematic review. European Journal of Gastroenterology & Hepatology 33:9, pages 1139-1147.
Crossref
Crossref
Juan C Nieto, Claudia Arajol, Loreto Carmona, Carlos Marras & Luis Cea-Calvo. (2021) Adherence to subcutaneous biological therapies in patients with inflammatory rheumatic diseases and inflammatory bowel disease: a systematic review. Immunotherapy 13:5, pages 433-458.
Crossref
Crossref
Carlo Lombardi, Diego Bagnasco & Giovanni Passalacqua. (2020) Biological agents for severe asthma: the evolution of the at-home self-injection approach. Current Opinion in Allergy & Clinical Immunology 20:4, pages 421-427.
Crossref
Crossref
Carlo Lombardi, Giovanni Passalacqua & Diego Bagnasco. (2019) Severe asthma, biologicals, and auto‐injection: Yes, no, may be!. Allergy 75:2, pages 444-445.
Crossref
Crossref
Nisha B Shah, Jennifer Haydek, James Slaughter, Jonathan R AshtonJrJr, Autumn D Zuckerman, Rochelle Wong, Francesca Raffa, Ailish Garrett, Caroline Duley, Kim Annis, Julianne Wagnon, Lawrence Gaines, Robin Dalal, Elizabeth Scoville, Dawn B Beaulieu, David Schwartz & Sara N Horst. (2020) Risk Factors for Medication Nonadherence to Self-Injectable Biologic Therapy in Adult Patients With Inflammatory Bowel Disease. Inflammatory Bowel Diseases 26:2, pages 314-320.
Crossref
Crossref